NCT06765499View on ClinicalTrials.gov

The Study Evaluating the Improvement of Nutritional Status and Frailty With Silkworm Pupa Powder Among Patients With Motor Neuron Disease

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 4, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Motor Neuron Disease (MND)Amyotrophic Lateral Sclerosis (ALS)
Interventions
OTHER

Chinese medicine - Silkworm pupa powder

Silkworm pupa contains high-quality animal protein and has a wide range of activities in antioxidant, antitumor, antibacterial, and immune enhancement, making it highly nutritious and medicinally valuable.

OTHER

Ultra-low dose silkworm pupa powder

0.5% of the effective components in the experimental group

Trial Locations (1)

310000

RECRUITING

Hangzhou First People's Hospital, Hangzhou

All Listed Sponsors
collaborator

Hangzhou Institute of Medicine Chinese Academy of Sciences

UNKNOWN

lead

First People's Hospital of Hangzhou

OTHER